Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Federico Moretti
Observed names:
F. Moretti,
Federico MORETTI,
Moretti Federico
Institutions:
Università Cattolica del Sacro Cuore,
University of Rome Tor Vergata,
Agostino Gemelli University Polyclinic,
Istituti di Ricovero e Cura a Carattere Scientifico
Observed institutions:
Università Cattolica del Sacro Cuore,
University of Rome Tor Vergata,
Agostino Gemelli University Polyclinic,
Policlinico Tor Vergata,
Istituti di Ricovero e Cura a Carattere Scientifico
ORCID:
0000-0001-6730-5296
Observed ORCIDs:
0000-0001-6730-5296,
0009-0000-1917-2329
OpenAlex ID:
A5059710655
Measurable Residual Disease (MRD) as a Surrogate Efficacy-Response Biomarker in AML
2023
·
Elisa Meddi
, Arianna Savi
, et al.
·
International Journal of Molecular Sciences
·
23
PDF
The ISTH DIC-score predicts early mortality in patients with non-promyelocitic acute myeloid leukemia
2024
·
Giovangiacinto Paterno
, Raffaele Palmieri
, et al.
·
Thrombosis Research
·
20
PDF
Use of Primary Prophylaxis with G-CSF in Acute Myeloid Leukemia Patients Undergoing Intensive Chemotherapy Does Not Affect Quality of Response
2025
·
Valeria Mezzanotte
, Giovangiacinto Paterno
, et al.
·
Journal of Clinical Medicine
·
10
PDF
Pneumocystis jirovecii pneumonia in patients with previously untreated acute myeloid leukaemia
2021
·
Giovangiacinto Paterno
, Luca Guarnera
, et al.
·
Mycoses
·
9
Polymer-Free Versus Biodegradable Polymer Drug-Eluting Stents in Coronary Artery Disease: Updated Systematic Review and Meta-Analysis of Clinical, Angiographic, and OCT Outcomes
2025
·
Marcello Marchetta
, Stefano Sasso
, et al.
·
Biomedicines
·
5
PDF
Validation of ICC hierarchical classification in secondary AML
2026
·
Enrico Attardi
, Marta Cipriani
, et al.
·
Blood Advances
·
4
PDF
Impact of fitness categorization according to SIE/SIES/GITMO criteria in therapy-related and AML-MRC receiving CPX-351
2025
·
Raffaele Palmieri
, Fabio Guolo
, et al.
·
Blood Advances
·
4
Leukemia cutis in a patient with acute myeloid leukemia undergoing Azacitidine-Venetoclax: case presentation and review of the literature
2025
·
Elisa Buzzatti
, Cristina Mauro
, et al.
·
Mediterranean Journal of Hematology and Infectious Diseases
·
4
Acute Leukemia and Latent Tuberculosis Infection in Italy: Quantiferon-tb Test Screening in a Low Tuberculosis Incidence Country
2024
·
Andrea Nunzi
, Luigi Della Valle
, et al.
·
Mediterranean Journal of Hematology and Infectious Diseases
·
4
PDF
Management and Treatment Strategies for Distal Tibia and Ankle Infections: Our Clinical Experience
2025
·
Antonio Mascio
, Chiara Comisi
, et al.
·
Journal of Clinical Medicine
·
3
PDF
Erythroid‐stimulating agents in VEXAS syndrome: A retrospective study from an Italian multicentre cohort
2025
·
E. Diral
, C. Campochiaro
, et al.
·
British Journal of Haematology
·
3
PDF
Reconstructive Orthopedic Surgery Using the Free Anterolateral Thigh Flap: Perspectives and Experience from a Single Trauma Center
2025
·
Mariagrazia Cerrone
, Virginia Cinelli
, et al.
·
Life
·
2
PDF
Impact of Time to Treatment Initiation on Quality of Response in Patients with Acute Myeloid Leukemia Receiving Intensive Chemotherapy
2025
·
Elisa Buzzatti
, Giovangiacinto Paterno
, et al.
·
Cancers
·
2
PDF
A fatal case of peritonitis due to colonic localization of acute myeloid leukemia
2025
·
Elisa Buzzatti
, Caterina Botti
, et al.
·
Annals of Hematology
·
2
PDF
Literature review and expert opinion on the treatment of high-risk acute myeloid leukemia in patients who are eligible for intensive chemotherapy
2024
·
Raffaele Palmieri
, Atto Billio
, et al.
·
Frontiers in Oncology
·
2
PDF
Occult central nervous system involvement guides therapeutic choices in blastic plasmacytoid dendritic cell neoplasms
2022
·
Elisa Buzzatti
, Giovangiacinto Paterno
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
2
Measurable residual disease as an actionable biomarker in acute myeloid leukemia. Ready or not?
2025
·
Francesco Buccisano
, Raffaele Palmieri
, et al.
·
Current Opinion in Oncology
·
1
Clinical Implications of Central Nervous System Involvement in Acute Myeloid Leukemia
2024
·
Giovangiacinto Paterno
, Flavia Mallegni
, et al.
·
Blood
·
1
PDF
Beyond Angiography: Integrating Intravascular Imaging and Physiology to Step up to Modern PCI
2026
·
Vincenzo Paragliola
, Federico Moretti
, et al.
·
Journal of Clinical Medicine
Tibial Component Malalignment in Total Ankle Arthroplasty
2026
·
Virginia Cinelli
, Gloria Assegbede
, et al.
·
Medicina
Use of Peripheral Blood to Measure Residual Disease by Flow Cytometry in Adult Acute Myeloid Leukemia: Final Report of the Prospective GIMEMA AML1310 Trial
2026
·
Luca Maurillo
, Francesco Buccisano
, et al.
·
American Journal of Hematology
PDF
De novo JAK2 ‐mutated acute myeloid leukaemia: Clinical outcomes and molecular features
2026
·
Luca Guarnera
, Emiliano Fabiani
, et al.
·
British Journal of Haematology
Incidence and Characteristics of Perianal Infections in CPX-351-Treated AML Patients
2026
·
Elisa Buzzatti
, Cristina Mauro
, et al.
·
Cancers
PDF
Establishing contemporary benchmarks for Acute Myeloid Leukemia outcomes and measurable residual disease: Real-world data utilization from the ELN-david MRD international working group
2025
·
Gail Roboz
, Tom Reuvekamp
, et al.
·
Blood
PDF
Specific Disease Entities - Vexas/ Vexas-like Disease
2025
·
Giulia Furnari
, Elisa Diral
, et al.
·
Leukemia Research
Show more works
View as search
Works count:
30
Citation count:
101
H-index:
5
I10-index:
3
Year
Topic
Type